Pulmonary Fibrosis and Telomerase Mutation Study
Phenotype of Pulmonary Fibrosis Associated With a Mutation of Telomerase
1 other identifier
observational
81
1 country
1
Brief Summary
This study is an observational and retrospective study of patients with pulmonary fibrosis associated or not with telomerase mutation. The purpose of this study is to describe in detail the cases with telomerase mutation in terms of features on CT scan, respiratory function and evolution, in comparison to control subjects with idiopathic pulmonary fibrosis and no telomerase mutation identified or family history.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2011
CompletedFirst Submitted
Initial submission to the registry
December 13, 2011
CompletedFirst Posted
Study publicly available on registry
December 29, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedFebruary 20, 2018
February 1, 2018
6 months
December 13, 2011
February 19, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Description of imaging pattern
Description of imaging pattern on representative CT scan at diagnosis.
at baseline only
Secondary Outcomes (2)
Pathology of the lung
at baseline only
Pulmonary function tests
from diagnosis to last follow-up, for an average of one year
Study Arms (2)
telomerase mutation
Patients with interstitial lung disease and telomerase mutation
control
Patients with idiopathic pulmonary fibrosis and without telomerase mutation
Eligibility Criteria
patients with pulmonary fibrosis with and without telomerase mutation
You may qualify if:
- Diffuse interstitial lung disease on CT scan
- Telomerase mutation analysis
You may not qualify if:
- Presence of connective tissue disease, or pneumoconiosis or drug induced lung disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Louis Pradel Hospital (Bâtiment A4)
Lyon, 69677, France
Related Links
Biospecimen
one blood sample is collected for genetic analysis of telomerase mutation
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
vincent Cottin, MD
Hospices civils de Lyon / University Lyon I
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 13, 2011
First Posted
December 29, 2011
Study Start
December 1, 2011
Primary Completion
June 1, 2012
Study Completion
December 1, 2015
Last Updated
February 20, 2018
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will share
Under analysis, publication in preparation